Current Closing Date for Applications:
Oct 12, 2007
The Post-Traumatic Stress Disorder (PTSD) Investigator-Initiated Research Award supports basic and clinically oriented research that will (1) result in substantial improvements over today’s approach to the treatment and clinical management of PTSD, (2) facilitate the development of novel preventive measures, and (3) enhance the quality of life of persons with PTSD. Proposals must include preliminary data relevant to PTSD research and the proposed project. In addition, if appropriate, a clear statistical plan of analysis should be included. Proposals containing clinical trials or clinical research are appropriate for this award. It is envisioned that access to Active Duty, National Guard, Reserve troops, and/or Military patient populations will be coordinated through a centralized DOD coordinating office, to be established prior to final recommendation of proposals for funding. Research proposal submissions that include Active duty, National Guard, Reserve troops, and/or Military patient populations must be accompanied by a Clinical Protocol (Appendix 7). Those proposals that score favorably during the scientific peer review and require access to Military patient populations will be forwarded to the centralized DOD coordinating office for consideration and review for availability and access to military patient populations prior to being recommended for funding. Please do not contact any Commander of Active duty, National Guard, Reserve troops and/or Military patient populations at this time or during preparation of your proposal submission. However we highly encourage you to collaborate with military researchers and clinicians. Access to Military populations will be handled by the coordinating center only. If selected for funding you will be provided guidance on how to obtain access to the appropriate population. Submissions that propose to recruit patients from Department of Veterans Affairs (VA) Medical Centers or use information from VA data systems must include an investigator with a VA appointment. This individual may be the principal investigator for the entire proposal or a VA collaborator willing to assume the role of principal VA investigator for the VA component of the proposal. Currently, there is a very limited ability to conduct human research in the CENTCOM Area of Responsibility. At present, this capability exists solely within select elements of the Multi-National Corps Iraq (MNC-I). There is no ability to conduct human research in Afghanistan at present. All research conducted within MNC-I must be in collaboration with an in theatre military investigator, undergo an in theatre review, and be approved by the MNC-I Command and the MNC-I designated Institutional Review Board. Given the constraints of wartime operations, investigators without an ongoing collaboration with a military investigator should strongly consider alternatives to the conduct of research in the wartime theatre. Note: DOD-supported human subjects research can only be conducted by institutions (to include those in theatre) with approved Federal Assurances of Compliance from Human Research Protection.
If you have difficulty accessing the full announcement electronically, please contact:
Pamela L. Fisher Grants Officer Phone 301-619-2805 Contracting/Grant Officer
Monday, July 16, 2007
Department of Defense (DoD) Traumatic Brain Injury (TBI) Concept Award
Current Closing Date for Applications:
Aug 23, 2007
The Traumatic Brain Injury (TBI) Concept Award supports the exploration of a new idea or innovative concept that could give rise to a testable hypothesis. Presentation of preliminary data is not required and is not consistent with the intent of this award mechanism. However, a rationale for the work must be provided. These awards provide PIs with the opportunity to pursue serendipitous observations. Proposals must describe how the new idea will enhance existing knowledge of traumatic brain injury or create an entirely new avenue for investigation. Research completed through a Concept Award may provide sufficient preliminary data to enable the PI to prepare a proposal for future research. The key initiative of the Concept Award is to spark new ideas, innovative technologies, and ground-breaking concepts that will drive the field of TBI research forward. Concepts that incorporate multiple disciplines are encouraged, as are research proposals involving collaborations among academia, Historically Black Colleges and Universities/Minority Institutions, industry, the military Services, the Department of Veterans Affairs, and other Federal Government agencies.
If you have difficulty accessing the full announcement electronically, please contact:
Pamela L. Fisher Grants Officer Phone 301-619-2805 Contracting/Grant Officer
Aug 23, 2007
The Traumatic Brain Injury (TBI) Concept Award supports the exploration of a new idea or innovative concept that could give rise to a testable hypothesis. Presentation of preliminary data is not required and is not consistent with the intent of this award mechanism. However, a rationale for the work must be provided. These awards provide PIs with the opportunity to pursue serendipitous observations. Proposals must describe how the new idea will enhance existing knowledge of traumatic brain injury or create an entirely new avenue for investigation. Research completed through a Concept Award may provide sufficient preliminary data to enable the PI to prepare a proposal for future research. The key initiative of the Concept Award is to spark new ideas, innovative technologies, and ground-breaking concepts that will drive the field of TBI research forward. Concepts that incorporate multiple disciplines are encouraged, as are research proposals involving collaborations among academia, Historically Black Colleges and Universities/Minority Institutions, industry, the military Services, the Department of Veterans Affairs, and other Federal Government agencies.
If you have difficulty accessing the full announcement electronically, please contact:
Pamela L. Fisher Grants Officer Phone 301-619-2805 Contracting/Grant Officer
Thursday, July 12, 2007
Advanced Tools and Technologies for Deep Brain Stimulation in Movement Disorders - SBIR (R43/R44)
Current Closing Date for Applications:
Multiple Receipt Dates - See Link to Full Announcement for details
This Funding Opportunity Announcement (FOA) invites Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) for projects to design and develop advanced tools and technologies that will lead to improved clinical treatment for Deep Brain Stimulation (DBS) patients. -Mechanism of Support. This FOA will utilize the SBIR (R43/R44) grant mechanisms for Phase I, Phase II, and Fast-Track applications and runs in parallel with a FOA of identical scientific scope, PA-07-395, that solicits applications under the Small Business Technology Transfer (STTR) (R41/R42) grant mechanisms. -Funds Available and Anticipated Number of Awards. For this funding opportunity, budgets up to $250,000 total costs per year and time periods up to 2 years for Phase I may be requested. Budgets up to $500,000 total costs per year and up to 3 years may be requested for Phase II. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications.
Link to Full Announcement
http://grants.nih.gov/grants/guide/pa-files/PA-07-396.html
If you have difficulty accessing the full announcement electronically, please contact:
NIH OER WebmasterFBOWebmaster@OD.NIH.GOVIf you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
Synopsis Modification History
The following files represent the modifications to this synopsis with the changes noted within the documents. The list of files is arranged from newest to oldest with the newest file representing the current synopsis. Changed sections from the previous document are shown in a light grey background.
Original Synopsis
Jul 12, 2007
Multiple Receipt Dates - See Link to Full Announcement for details
This Funding Opportunity Announcement (FOA) invites Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) for projects to design and develop advanced tools and technologies that will lead to improved clinical treatment for Deep Brain Stimulation (DBS) patients. -Mechanism of Support. This FOA will utilize the SBIR (R43/R44) grant mechanisms for Phase I, Phase II, and Fast-Track applications and runs in parallel with a FOA of identical scientific scope, PA-07-395, that solicits applications under the Small Business Technology Transfer (STTR) (R41/R42) grant mechanisms. -Funds Available and Anticipated Number of Awards. For this funding opportunity, budgets up to $250,000 total costs per year and time periods up to 2 years for Phase I may be requested. Budgets up to $500,000 total costs per year and up to 3 years may be requested for Phase II. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications.
Link to Full Announcement
http://grants.nih.gov/grants/guide/pa-files/PA-07-396.html
If you have difficulty accessing the full announcement electronically, please contact:
NIH OER WebmasterFBOWebmaster@OD.NIH.GOVIf you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
Synopsis Modification History
The following files represent the modifications to this synopsis with the changes noted within the documents. The list of files is arranged from newest to oldest with the newest file representing the current synopsis. Changed sections from the previous document are shown in a light grey background.
Original Synopsis
Jul 12, 2007
Understanding and Treating Generalized and Focal Dystonias - R01 and R21
Current Closing Date for Applications:
Multiple Receipt Dates - See Link to Full Announcement for details
The National Institute of Neurological Disorders and Stroke (NINDS), National Institute of Child Health and Human Development (NICHD), National Institute on Deafness and Other Communication Disorders (NIDCD), National Institute of Environmental Health Sciences (NIEHS), in conjunction with the Dystonia Medical Research Foundation (DMRF) and the Bachmann-Strauss Dystonia and Parkinson Foundation, Inc., invite research grant applications aimed at understanding or treating generalized and focal dystonias. The aim of this FOA is to encourage basic, translational and clinical studies, to determine the patho-physiology of dystonia, to stimulate the development of basic and translational resources to further dystonia research, to accelerate research into promising therapeutic approaches for dystonia, and to stimulate progress in dystonia research through encouraging and facilitating interdisciplinary interactions. -Mechanism of Support. This funding opportunity will utilize the NIH R01 mechanism, and runs in parallel with another FOA of identical scientific scope (PA-07-398) that solicit applications under the NIH Exploratory/Developmental grant mechanism (R21). -Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications.
Link to Full Announcement
http://grants.nih.gov/grants/guide/pa-files/PA-07-397.html
If you have difficulty accessing the full announcement electronically, please contact:
NIH OER WebmasterFBOWebmaster@OD.NIH.GOVIf you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
Multiple Receipt Dates - See Link to Full Announcement for details
The National Institute of Neurological Disorders and Stroke (NINDS), National Institute of Child Health and Human Development (NICHD), National Institute on Deafness and Other Communication Disorders (NIDCD), National Institute of Environmental Health Sciences (NIEHS), in conjunction with the Dystonia Medical Research Foundation (DMRF) and the Bachmann-Strauss Dystonia and Parkinson Foundation, Inc., invite research grant applications aimed at understanding or treating generalized and focal dystonias. The aim of this FOA is to encourage basic, translational and clinical studies, to determine the patho-physiology of dystonia, to stimulate the development of basic and translational resources to further dystonia research, to accelerate research into promising therapeutic approaches for dystonia, and to stimulate progress in dystonia research through encouraging and facilitating interdisciplinary interactions. -Mechanism of Support. This funding opportunity will utilize the NIH R01 mechanism, and runs in parallel with another FOA of identical scientific scope (PA-07-398) that solicit applications under the NIH Exploratory/Developmental grant mechanism (R21). -Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications.
Link to Full Announcement
http://grants.nih.gov/grants/guide/pa-files/PA-07-397.html
If you have difficulty accessing the full announcement electronically, please contact:
NIH OER WebmasterFBOWebmaster@OD.NIH.GOVIf you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
Advanced Tools and Technologies for Deep Brain Stimulation in Movement Disorders - STTR (R41/R42)
Current Closing Date for Applications:
Multiple Receipt Dates - See Link to Full Announcement for details
This Funding Opportunity Announcement (FOA) invites Small Business Technology Transfer Research (STTR) grant applications from small business concerns (SBCs) for projects to design and develop advanced tools and technologies that will lead to improved clinical treatment for Deep Brain Stimulation (DBS) patients. -Mechanism of Support. This FOA will utilize the STTR (R41/R42) grant mechanisms for Phase I, Phase II, and Fast-Track applications and runs in parallel with a FOA of identical scientific scope, PA-07-396, that solicits applications under the Small Business Innovation Research (SBIR) (R43/R44) grant mechanisms. -Funds Available and Anticipated Number of Awards. For this funding opportunity, budgets up to $250,000 total costs per year and time periods up to 2 years for Phase I may be requested. Budgets up to $500,000 total costs per year and up to 3 years may be requested for Phase II. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications.
Link to Full Announcement
http://grants.nih.gov/grants/guide/pa-files/PA-07-395.html
If you have difficulty accessing the full announcement electronically, please contact:
NIH OER WebmasterFBOWebmaster@OD.NIH.GOVIf you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
Synopsis Modification History
The following files represent the modifications to this synopsis with the changes noted within the documents. The list of files is arranged from newest to oldest with the newest file representing the current synopsis. Changed sections from the previous document are shown in a light grey background.
Original Synopsis
Jul 12, 2007
Multiple Receipt Dates - See Link to Full Announcement for details
This Funding Opportunity Announcement (FOA) invites Small Business Technology Transfer Research (STTR) grant applications from small business concerns (SBCs) for projects to design and develop advanced tools and technologies that will lead to improved clinical treatment for Deep Brain Stimulation (DBS) patients. -Mechanism of Support. This FOA will utilize the STTR (R41/R42) grant mechanisms for Phase I, Phase II, and Fast-Track applications and runs in parallel with a FOA of identical scientific scope, PA-07-396, that solicits applications under the Small Business Innovation Research (SBIR) (R43/R44) grant mechanisms. -Funds Available and Anticipated Number of Awards. For this funding opportunity, budgets up to $250,000 total costs per year and time periods up to 2 years for Phase I may be requested. Budgets up to $500,000 total costs per year and up to 3 years may be requested for Phase II. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications.
Link to Full Announcement
http://grants.nih.gov/grants/guide/pa-files/PA-07-395.html
If you have difficulty accessing the full announcement electronically, please contact:
NIH OER WebmasterFBOWebmaster@OD.NIH.GOVIf you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
Synopsis Modification History
The following files represent the modifications to this synopsis with the changes noted within the documents. The list of files is arranged from newest to oldest with the newest file representing the current synopsis. Changed sections from the previous document are shown in a light grey background.
Original Synopsis
Jul 12, 2007
Alzheimer's Disease Demonstration Grants to States (ADDGS) Program
Administration on Aging
Current Closing Date for Applications:
Aug 28, 2007 See link to full announcement for details
The statutory authority for grant awards for the Alzheimer's Disease Demonstration Grants to States program is contained in Sec. 398 of the Public Health Service Act (P.L. 78-410; 42 U.S.C. 280c-3). It was amended by the Home Health Care and Alzheimer's Disease Amendments of 1990 (PL 101-557) and by the Health Professions Education Partnerships Act of 1998 (PL 105-392). Section 398 of the Public Health Service Act (42 U.S.C. 398 et seq.), as amended, requires that grantees provide a 25% match (cash or in-kind). Waivers to this match requirement are not allowed. AoA plans to fund approximately six (6) to eight (8) new cooperative agreements nationwide through this competition. The cooperative agreements will be funded at a federal share of up to $400,000, with most awardees expected to receive $250,000 for a project period of eighteen months (contingent on the availability of funds.) If the applicant requests more than $250,000, up to the maximum award amount of $400,000, the proposal must clearly detail the reason(s) for requesting funds above $250,000 (i.e., the research project to be implemented does not have the necessary tools, such as training manuals, to facilitate project start-up; the potential number of people affected and the degree of enduring change in the state's system of long term care for people with ADRD or their caregivers; and/or the measurement tools required to ensure the fidelity of the proposed project are substantial.) A total of $1,700,000 has been allocated for these cooperative agreements. Projects carried out using ADDGS grant funds focus on: 1) Coordinating the development and operation with public and private organizations of diagnostic, treatment, care services provided within the State to individuals with Alzheimer's disease and related dementias and to the families and care providers of such individuals; 2) Providing ADDGS-statutorily defined direct services, which include, and are limited to, home health care, personal care, day care, companion services, short-term care in health facilities, and other respite care to individuals with Alzheimer's disease and related dementias who are living in single family homes or congregate settings. At least 50% of the total federal grant funds are to be spent on providing these direct services and no more than 10% of the total project funds can be spent on administrative costs; 3) Improving the access of such individuals to home-based or community-based long-term care services, particularly such individuals who are members of racial or ethnic minority groups, who have limited proficiency in speaking the English language, or who live in rural areas; and 4) Providing to health care providers, to individuals with Alzheimer's disease and related dementias, to the families of such individuals, to organizations established for such individuals and such families, and to the general public, information with respect to: (A) diagnostic services, treatment services, and related services available to such individuals and to the families of such individuals; (B) sources of assistance in obtaining such services, including assistance under entitlement programs; and (C) the legal rights of such individuals and such families. Alzheimer's disease (AD) is a progressive, degenerative disease of the brain, and the most common form of dementia. Discovered and described in 1906 by Dr. Alois Alzheimer, AD now affects approximately 5 million Americans. Unless a cure or prevention is found, it is estimated that the number of Americans with Alzheimer's will climb to 14 million by the middle of the next century. Although AD is not a normal part of aging, one in 10 persons over 65 and nearly half of those over 85 may have Alzheimer's disease. A small percentage of people in their 30s and 40s also develop the disease. Although AD eventually results in death, the disease can progress for years. A person with AD lives an average of 8 years, but can live as many as 20 years or more from the onset of symptoms. To focus attention on this need, to encourage states to develop models of assistance for persons with Alzheimer's disease and related dementias (ADRD), and to encourage close coordination and incorporation of those services into the broader home and community based care system, Congress funded the Alzheimer's Disease Demonstration Grants to States (ADDGS) program in 1991. Congress transferred the administration of the program to the AoA in 1998, in an effort to ensure coordination with other programs for older Americans. To date, the ADDGS program has proven successful in targeting service and system development to traditionally underserved populations, including ethnic minorities, low-income and rural families coping with Alzheimer's disease.
Link to Full Announcement
http://AoA.gov
If you have difficulty accessing the full announcement electronically, please contact:
Lori StalbaumLori.Stalbaum@aoa.hhs.govLori Stalbaum
Current Closing Date for Applications:
Aug 28, 2007 See link to full announcement for details
The statutory authority for grant awards for the Alzheimer's Disease Demonstration Grants to States program is contained in Sec. 398 of the Public Health Service Act (P.L. 78-410; 42 U.S.C. 280c-3). It was amended by the Home Health Care and Alzheimer's Disease Amendments of 1990 (PL 101-557) and by the Health Professions Education Partnerships Act of 1998 (PL 105-392). Section 398 of the Public Health Service Act (42 U.S.C. 398 et seq.), as amended, requires that grantees provide a 25% match (cash or in-kind). Waivers to this match requirement are not allowed. AoA plans to fund approximately six (6) to eight (8) new cooperative agreements nationwide through this competition. The cooperative agreements will be funded at a federal share of up to $400,000, with most awardees expected to receive $250,000 for a project period of eighteen months (contingent on the availability of funds.) If the applicant requests more than $250,000, up to the maximum award amount of $400,000, the proposal must clearly detail the reason(s) for requesting funds above $250,000 (i.e., the research project to be implemented does not have the necessary tools, such as training manuals, to facilitate project start-up; the potential number of people affected and the degree of enduring change in the state's system of long term care for people with ADRD or their caregivers; and/or the measurement tools required to ensure the fidelity of the proposed project are substantial.) A total of $1,700,000 has been allocated for these cooperative agreements. Projects carried out using ADDGS grant funds focus on: 1) Coordinating the development and operation with public and private organizations of diagnostic, treatment, care services provided within the State to individuals with Alzheimer's disease and related dementias and to the families and care providers of such individuals; 2) Providing ADDGS-statutorily defined direct services, which include, and are limited to, home health care, personal care, day care, companion services, short-term care in health facilities, and other respite care to individuals with Alzheimer's disease and related dementias who are living in single family homes or congregate settings. At least 50% of the total federal grant funds are to be spent on providing these direct services and no more than 10% of the total project funds can be spent on administrative costs; 3) Improving the access of such individuals to home-based or community-based long-term care services, particularly such individuals who are members of racial or ethnic minority groups, who have limited proficiency in speaking the English language, or who live in rural areas; and 4) Providing to health care providers, to individuals with Alzheimer's disease and related dementias, to the families of such individuals, to organizations established for such individuals and such families, and to the general public, information with respect to: (A) diagnostic services, treatment services, and related services available to such individuals and to the families of such individuals; (B) sources of assistance in obtaining such services, including assistance under entitlement programs; and (C) the legal rights of such individuals and such families. Alzheimer's disease (AD) is a progressive, degenerative disease of the brain, and the most common form of dementia. Discovered and described in 1906 by Dr. Alois Alzheimer, AD now affects approximately 5 million Americans. Unless a cure or prevention is found, it is estimated that the number of Americans with Alzheimer's will climb to 14 million by the middle of the next century. Although AD is not a normal part of aging, one in 10 persons over 65 and nearly half of those over 85 may have Alzheimer's disease. A small percentage of people in their 30s and 40s also develop the disease. Although AD eventually results in death, the disease can progress for years. A person with AD lives an average of 8 years, but can live as many as 20 years or more from the onset of symptoms. To focus attention on this need, to encourage states to develop models of assistance for persons with Alzheimer's disease and related dementias (ADRD), and to encourage close coordination and incorporation of those services into the broader home and community based care system, Congress funded the Alzheimer's Disease Demonstration Grants to States (ADDGS) program in 1991. Congress transferred the administration of the program to the AoA in 1998, in an effort to ensure coordination with other programs for older Americans. To date, the ADDGS program has proven successful in targeting service and system development to traditionally underserved populations, including ethnic minorities, low-income and rural families coping with Alzheimer's disease.
Link to Full Announcement
http://AoA.gov
If you have difficulty accessing the full announcement electronically, please contact:
Lori StalbaumLori.Stalbaum@aoa.hhs.govLori Stalbaum
Wednesday, July 11, 2007
Defense University Research Instrumentation Program (DURIP) - for Proposal Submission to Navy
Current Closing Date for Applications:
Aug 21, 2007
The Department of Defense (DoD) announces the Fiscal Year 2008 Defense University Research Instrumentation Program (DURIP), a part of the University Research Initiative (URI). DURIP is designed to improve the capabilities of U.S. institutions of higher education (hereafter referred to as “universities”) to conduct research and to educate scientists and engineers in areas important to national defense, by providing funds for the acquisition of research equipment. The research areas of interest for the administering agencies are available on-line at the following addresses: Army Research Office: http://www.aro.army.mil/ (select “For the Researcher” and then “Funding Opportunities”) See BAA W911NF-07-R-0003 Office of Naval Research: http://www.onr.navy.mil/ (select “ONR Science and Technology Departments”) (Refer questions about appropriate program managers to contact to Dr. Bill Lukens, 703-696-4668) Air Force Office of Scientific Research: http://www.afosr.af.mil/ (select “Research Areas”) For detailed information regarding technical goals, potential proposers are advised to refer to the announcements cited above and may contact DoD program managers listed therein to explore mutual interest before submitting proposals. A proposal may be submitted to more than one agency; however, only one award will be given. A central purpose of the DURIP is to provide equipment to enhance research-related education. Therefore proposals must address the impact of the equipment on the institution’s ability to educate students, through research, in disciplines important to DoD missions. This announcement seeks proposals to purchase instrumentation in support of research areas of interest to the DoD, including areas of research supported by the administering agencies.
Link to Full Announcement
Link to All ONR BAA's
If you have difficulty accessing the full announcement electronically, please contact:
Kristin Fuller Contract Specialist Phone 703-696-4591 GRANTS.GOV QUESTIONS ONLY
Aug 21, 2007
The Department of Defense (DoD) announces the Fiscal Year 2008 Defense University Research Instrumentation Program (DURIP), a part of the University Research Initiative (URI). DURIP is designed to improve the capabilities of U.S. institutions of higher education (hereafter referred to as “universities”) to conduct research and to educate scientists and engineers in areas important to national defense, by providing funds for the acquisition of research equipment. The research areas of interest for the administering agencies are available on-line at the following addresses: Army Research Office: http://www.aro.army.mil/ (select “For the Researcher” and then “Funding Opportunities”) See BAA W911NF-07-R-0003 Office of Naval Research: http://www.onr.navy.mil/ (select “ONR Science and Technology Departments”) (Refer questions about appropriate program managers to contact to Dr. Bill Lukens, 703-696-4668) Air Force Office of Scientific Research: http://www.afosr.af.mil/ (select “Research Areas”) For detailed information regarding technical goals, potential proposers are advised to refer to the announcements cited above and may contact DoD program managers listed therein to explore mutual interest before submitting proposals. A proposal may be submitted to more than one agency; however, only one award will be given. A central purpose of the DURIP is to provide equipment to enhance research-related education. Therefore proposals must address the impact of the equipment on the institution’s ability to educate students, through research, in disciplines important to DoD missions. This announcement seeks proposals to purchase instrumentation in support of research areas of interest to the DoD, including areas of research supported by the administering agencies.
Link to Full Announcement
Link to All ONR BAA's
If you have difficulty accessing the full announcement electronically, please contact:
Kristin Fuller Contract Specialist Phone 703-696-4591 GRANTS.GOV QUESTIONS ONLY
Subscribe to:
Posts (Atom)